Research Identifies Potential Link Between Iron Metabolism, CD71-Expressing Cells, And Lipid Peroxidation In Patients With Myasthenia Gravis

Rare Disease Advisor (8/12, Ozkaya) reports, “There may be a link between iron metabolism, CD71-expressing cells, and lipid peroxidation in” patients with “myasthenia gravis (MG), according to a new study.” The research “also showed that treatment with pyridostigmine reduced the levels of CD71-expressing cells as well as lipid peroxidation,” which “suggests that the treatment may have immunomodulatory and antioxidant effects either directly or indirectly, the authors said.” The findings were published in International Immunopharmacology.